Is HER2 Too Much Bother in Lung Cancer? Is HER2 Too Much Bother in Lung Cancer?
Dr. Jack West reports on a study assessing HER2/neu as a potential target in non-small cell lung cancer -- and finds cause for pause in the rush to identify more therapeutic targets. Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Viewpoint Source Type: news
More News: Cancer | Cancer & Oncology | Health | Hematology | HER2 | Lung Cancer | Non-Small Cell Lung Cancer | Study